Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MacFibOsis
NCT04473742Completed
- Sponsor
- CHU Rennes
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Rennes. Primary endpoint: Efferocytosis Index (EI). Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04473742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04473742.